Dr. Lisa Philp and Professor Colleen Nelson, from the QUT Faculty of Health's School of Biomedical Science, are developing drugs to fight advanced prostate cancer that could also prevent and or treat acute respiratory distress ...
Nov 16, 2020
0
28
Leukemias and lymphomas are life-threatening malignancies affecting white blood cells and the immune system; fortunately, radiotherapy and chemotherapy, combined with stem cell therapy, can improve survival significantly. ...
Nov 9, 2020
0
2
With the advent of pharmacogenomics, machine learning research is well underway to predict patients' drug response that varies by individual from the algorithms derived from previously collected data on drug responses. Entering ...
Nov 2, 2020
0
15
An international team of researchers has found that selpercatinib, a drug that precisely targets cancers driven by mutations or alterations in the gene RET, was effective at shrinking tumors in patients with nonsmall cell ...
Sep 28, 2020
0
1
Selpercatinib (Retevmo), a drug targeted precisely against cancers driven by mutations or alterations in the gene RET, was effective in a clinical trial at shrinking tumors in patients with medullary thyroid cancer, with ...
Aug 26, 2020
0
36
Researchers at the University of Alberta have found a way to deliver anti-cancer drugs with more precision, which could increase the effectiveness of many cancer treatments.
Jul 3, 2020
0
136
Scientists have used 3-D models to break down the DNA behavior of cancer cells, in a breakthrough new study which could revolutionize treatment for the disease.
May 11, 2020
0
43
KAIST researchers have identified mechanisms that relay prior acquired resistance to the first-line chemotherapy to the second-line targeted therapy, fueling a "domino effect" in cancer drug resistance. Their study featured ...
Feb 10, 2020
0
1
Walter and Eliza Hall Institute researchers have narrowed the focus on which survival proteins are important for the survival of B cell lymphomas, eliminating the protein BCL-W from the "suspect list."
Feb 5, 2020
0
31
There's a new treatment option available for patients with AL amyloidosis: daratumumab.
Jan 27, 2020
0
10
